Claim Missing Document
Check
Articles

Found 2 Documents
Search

Wolbachia-Based Dengue Control Strategy Against Insecticide-Resistant Aedes Aegypti: A Literature Review Ni Kadek Meta Jayanti; Putu Ayu Asri Damayanti; I Made Sudarmaja
Syntax Literate Jurnal Ilmiah Indonesia
Publisher : Syntax Corporation

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36418/syntax-literate.v11i5.64406

Abstract

Dengue Hemorrhagic Fever (DHF) is a tropical disease associated with dengue virus infection and remains one of the largest vector-borne health problems worldwide. Approximately 390 million cases are caused annually by dengue virus infection, which is transmitted through the bite of the Aedes aegypti mosquito. Therefore, this literature review aims to explore the biomolecular mechanisms underlying the utilization of Wolbachia bacteria, evaluate the potential and effectiveness of this method in dengue vector control, and analyze various challenges and opportunities related to the latest developments in the implementation of Wolbachia-based strategies as a long-term dengue vector control approach. A literature search was conducted using the keywords “Wolbachia,” “Dengue,” “Resistance,” and “Aedes” through PubMed, ScienceDirect, and Scopus, with a focus on studies reporting dengue incidence and mosquito population dynamics. Wolbachia pipientis is an intracellular bacterium capable of inhibiting the replication of arboviruses, including the dengue virus, within the mosquito body by utilizing lipid resources to suppress viral replication and activate the immune system of the Aedes aegypti mosquito. According to research findings from several countries, the implementation of this method has successfully reduced the number of dengue cases and lowered the risk of dengue infection by approximately 40–77%, with sustained reductions observed over longer periods. Economic analyses of this intervention have also demonstrated that the method is cost-efficient, with a cost per Disability-Adjusted Life Year (DALY) of less than USD 1,500 and healthcare savings of up to USD 538,000 per 1,000 population. Overall, the utilization of Wolbachia has proven to be both effective and cost-efficient in reducing dengue fever incidence and controlling mosquito populations.
The Potential of Curcuma Xanthorrhiza as An Adjuvant Therapy for Malaria: A Narrative Review Ni Kadek Rita Rosadi; Dewa Ayu Agus Sri Laksemi; I Made Sudarmaja
Indonesian Journal of Global Health Research Vol. 8 No. 5 (2026): Indonesian Journal of Global Health Research
Publisher : GLOBAL HEALTH SCIENCE GROUP

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37287/ijghr.v8i5.2467

Abstract

Malaria continues to be a major global health issue, associated with high rates of morbidity and mortality. The primary treatment is artemisinin-based combination therapy (ACT), however ts effectiveness is being threatened by resistance associated with mutations in the kelch13 (K13) gene. Furthermore, an excessive inflammatory response also plays a role in malaria pathogenesis, making immunomodulation-based therapeutic approaches an important strategy. This study aims to evaluate the potential and mecahnism of Curcuma xanthorrhiza (Javanese turmeric or temulawak) as an antiplasmodial agent and adjuvant therapy. This narrative review aimed to evaluate the potential of Curcuma xanthorrhiza as an adjuvant therapy for malaria. Literature was collected from PubMed, ScienceDirect, and Google Scholar for studies published between 2010 and 2025 using keywords related to malaria, Curcuma xanthorrhiza, artemisinin resistance, oxidative stress, and immunomodulation. A total of 268 records were identified through the database search. After duplicate removal and eligibility screening, 39 articles met the inclusion criteria and were included in this narrative review.  Selected studies included experimental research, reviews, and preclinical investigations relevant to the pharmacological activity of Curcuma xanthorrhiza in malaria management. Evidence indicates that bioactive compounds such as xanthorrhizol, curcuminoids, and terpenoids exhibit moderate antiplasmodial activity and significantly regulate inflammatory pathways through inhibition of nuclear factor-kappa B (NF-κB), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and pro-inflammatory cytokines including TNF-α and IL-6. In addition, antioxidant activity contributes to reducing oxidative tissue damage associated with malaria pathogenesis. Although its direct antiparasitic potency remains inferior to artemisinin-based combination therapy (ACT), Curcuma xanthorrhiza demonstrates promising potential as a host-directed adjunctive therapy capable of enhancing immune homeostasis and mitigating malaria-associated complications. However, current evidence is predominantly limited to in vitro and animal studies.